News archive

April 11, 2023
Update on Sensor longevity    Today, Lifecare is pleased to announce that a sensor first used in our ongoing Clinical Development Study has confirmed an operational longevity of 12 weeks in a continued laboratory (in vitro) set up. This is yet another important milestone in the development of our Sencell technology for Continuous Glucose Monitoring […]
Read more
March 31, 2023
Update on Clinical Development Study   The Clinical Development Study with the Sencell sensor will continue for a few more weeks.   – We operate complex and pioneering sensor technology and strive to ensure high quality at all stages of the process. We therefore want to extend the Clinical Development Study by a few weeks […]
Read more
March 28, 2023
For Lifecare 2022 was characterized by confirmation of the technology, Clinical Development Study, and building an organization that makes us even more robust and competent to face upcoming challenges. – Important milestone achievements naturally provide a good basis for the ongoing work related to the glucose sensor, CEO Joacim Holter states. Lifecare’s Annual Report 2022 […]
Read more
March 23, 2023
Successful ISO audit at Lifecare Laboratory in Germany   Lifecare is pleased to announce that its wholly owned subsidiary Lifecare Laboratory GmbH in Mainz, Germany, has been successfully audited as part of the upcoming ISO certification. “It is reassuring that our operational organization has passed this audit without any major findings. This is a good […]
Read more
February 28, 2023
Q4 2022 Report  Lifecare AS will present Q4 2022 Report on Tuesday 28 February. The webcast will be for all shareholders and interested parties at 12:30 – 13:15 CET. Lifecare CEO Joacim Holter will participate in the webcast. There will be a Q&A session following the presentation. The webcast will be available here: Link to Teams meeting […]
Read more
February 22, 2023
  Important week for Lifecare in Berlin at the 16th international conference on Advanced Technologies & Treatments for Diabetes (ATTD)   The upcoming days Lifecare will be productive and important for Lifecare in in Berlin where two presentations will be held at the prestigious conference ATTD. The company will also attend the steering committee of the […]
Read more
February 6, 2023
Sensor longevity breakthrough in Lifecare Ongoing clinical development study confirms Lifecare’s expectation of a sensor longevity that far exceeds the lifetime of existing and commercially available needle sensors for glucose monitoring.   CSO Prof. Andreas Pfützner and CEO Joacim Holter   Today Lifecare can report that sensors used in a three-day clinical study continue to […]
Read more
January 26, 2023
New collaboration strengthens Lifecare’s development Lifecare recently entered into a partnership with Goethe University Frankfurt am Main.   – Complementary expertise, further strengthening of our product development as well as strengthening our potential recruitment base were decisive for the new agreement with a professionally strong research environment, says CEO Joacim Holter. CEO Joacim Holter and CSO […]
Read more
January 5, 2023
2022 was a very good year for Lifecare as a company and we welcome 2023 expecting continued significant progress in our mission to make life easier for patients with diabetes.    Joacim Holter, CEO at Lifecare    Throughout 2022 Lifecare reached several milestone events:     In June, Lifecare disclosed the by far most important development events […]
Read more
December 6, 2022
Lifecare announces all-time high revenue in their financial reporting for Q3 2022. – We are pleased to see a positive outcome of the investments we have made. Furthermore, this provides a base for Lifecare´s continued research and product development, says CEO Joacim Holter.    Joacim Holter, CEO at Lifecare   The consolidated group financials show […]
Read more